可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Timmer JR, van der Horst IC, Ottervanger JP, et al. Prognostic value of admission glucose in nondiabetic patients with myocardial infarction[J]. Am Heart J,2004, 148(3):399-404.
[2]Ishihara M, Kojima S, Sakamoto T, et al. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era[J]. Am Heart J,2005,150(4):814-820.
[3]Zhao ZQ,Zang YM. Alternative cardioprotective strategy during reperfnsion:postconditioning vs preconditioning[J]. 心脏杂志,2006,18(1):1-13.
[4]Gao F, Yue TL, Shi DW, et al. p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation[J]. Cardiovasc Res,2002,53(2):414-422.
[5]Kersten JR, Schmeling TJ, Orth KG, et al. Acute hyperglycemia abolishes ischemic preconditioning in vivo[J]. Am J Physiol,1998,275(2 Pt 2):H721-H725.
[6]Devos P, Chiolero R, Van den Berghe G, et al. Glucose, insulin and myocardial ischaemia[J]. Curr Opin Clin Nutr Metab Care,2006, 9(2):131-139.
[7]Cai L, Li W, Wang G, et al. Hyperglycemiainduced apoptosis in mouse myocardium: mitochondrial cytochrome Cmediated caspase3 activation pathway[J]. Diabetes, 2002,51(6):1938-1948.